Research

The JDRF has established a set ofcure therapeutics to guide its research funding efforts. These research goal areas hold the greatest potential to lead to breakthrough cures and treatments for type 1 diabetes and its complications: Beta Cell Therapies, Immune Therapies, Glucose Control and Complications Therapies.

Taking a part in finding a cure.

The cornerstone of any non-profit raising funds for research is to have volunteers for clinical trials. In 2005 JDRF funded only 5 clinical trials. Today JDRF is funding more than 40. People with type 1 diabetes are taking an active role in helping to find better treatments and cures by taking part in research. With the increase in the number of clinical trials finding participants for those trials is harder than ever. If you are interested in participating in a clinical trial you may access available trials through JDRF’s Clinical Trial Connection.

Our Chapter is alsofortunate to have Cynthia Kemp, a local JDRF volunteer and mother of a type 1 child, working for the University of Florida’s Diabetes Research Center to raise awareness and participation in type 1 diabetes research. Families are available to share their personal stories of how particpating in a trial helped them – either improving their health or making them feel responsible for actively seeking better treatments and cures. UF researchers are also available for phone interviews.

“Florida: A Powerhouse of Type 1 Diabetes Research”

You can honestly say that your research dollars are staying locally! The State of Florida ahs a high concentration of research institutions leading the global effort to find a cure for type 1 diabetes and, until then, work to reduce the complications that accompany this devasting disease. Researchers are available for phone interviews, as well as JDRF national staff to discuss JDRF funded research in the state. The research institutions include:

  • University of Florida
  • University of South Florida
  • The Jaeb Center for Health Research
  • University of Miami

Clinical Trials Available at the University of Florida (UF):

  • TrialNet Natural History Study – Eligible: 1st degree relatives age 1-45 or 2nd degree relatives age 1-20. High risk could be eligible to participate in a prevention study “The Oral Insulin Study Prevention Study.” Call: Diabetes Research Program at 352-334-0857; Elena Hicks, 352-334-0866; or Annie Abraham at352-334-1358.
  • AntiCD3 (Prevention) - Eligible: Participants in the TrialNet Natural History Study that have at least two positive autoantibodies and abnormal glucose tolerance will qualify to be screened for the AntiCD3 Prevention Study. Contact Jessica Fergusion, RN, BSN at 352-334-0866.
  • Neulasta/GCSF (Intervention) – Eligible: New onset (within 6 months) age 12 or older. Call: Diabetes Research Program at 352-334-0857; Dr. Mike Haller, MD,352-279-9264; Miriam Cintron, 352-273-5580; Dr. Des Shatz, MD,352-219-0230 (cell); or Annie Abraham at352-334-1358.
  • ATG/GCSF (Intervention) – Eligible: Diagnosis at least 4 months & less than 2 years – Ages 18 & older. Call: Diabetes Research Program, 352-334-0857; Dr. Mike Haller, MD, 352-273-9264; Mary Alice Dennis, RN, 352-273-9265; or Annie Abraham at 352-334-1358.
  • Pediatric Diabetes Consortium (New Onset) – Eligible: Newly diagnosed less than 19 years old. Call Diabetes Research Program, 352-334-0857 or Erica Dougherty at 352-334-0281.
  • Cytokine Production by Cord Blood Cells – Eligible: Pregnant women over age 18, delivering at Shands. Call Melissa Rawley-Paye at 352-273-9498, or Dr. Michael Clare-Salzler, MDat 352-273-7839.
  • Immunological Studies in T1DM (Type 1 Diabetes Melitis) – Eligible: Established patients, new onset, and 1st degree relatives. Call Diabetes Research Program, 352-334-0857; Lindsey Bierschenk, 352-273-9268; Clive Wasserfall, 352-494-3646 (cell); or Annie Abraham, 352-334-1358.

Visit the UF Diabetes Center of Excellence website for the most up-to-date list of research studies.

Clinical Trials Available at the University of South Florida (USF):

  • T1D Exchange Clinical Registry – Eligible: Established type 1s diagnosed 3 or more years. Contact Craig Bobik, MPH, at (813) 396-2595.
  • TrialNet Natural History Study – Eligible: 1st degree relatives age 1-45 or 2nd degree relatives age 1-20. High risk could be eligible to participate in a prevention study “The Oral Insulin Study Prevention Study.” Contact Craig Bobik, MPH, at (813) 396-2595.

Visit the USF Diabetes Center website for the most up-to-date list of research studies.Diabetes Research Institute (DRI) Studies in Miami, Florida:Visit the Diabetes Research Institute (DRI) website for information on clinical trials are available in the following areas:· Islet transplantation· Intervention and prevention studies